Gene Therapy for Rare Brain Disease Effective, but Comes With Blood Cancer Risk

Published Date: 11 Oct 2024

10% of patients in trials leading to eli-cel's approval developed MDS or AML

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

In a study, immune detection of oral cancers is linked to obesity.

2.

FDA approves rivanetin as the first-line treatment for lung cancer.

3.

Extended Maintenance with Imatinib Enhances Disease-Free Survival in High-Risk GIST.

4.

Regular physical activity before cancer diagnosis may lower progression and death risks

5.

Alternative Medicine for Breast Cancer: Study Raises Concern


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot